BLRX Competitors & Alternatives
Compare BioLineRX Ltd with similar stocks in the same industry
Pharmaceutical Preparations
BLRX
Main Stock$3.01
Tradestie Score
60
Market Cap
$16.50M
Revenue Growth
-0.9%
Analyst Upside
+763.8%
Top Competitors
553 stocks in Pharmaceutical Preparations| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$1044.13
|
$739.95B | 50.2 | 55 | Compare |
|
JNJ
Johnson & Johnson
|
$230.75
|
$448.07B | 20.6 | 63 | Compare |
|
ABBV
ABBVIE INC.
|
$225.64
|
$431.71B | 166.4 | 61 | Compare |
|
NVO
Novo-Nordisk A/S
|
$58.93
|
$262.92B | 15.8 | 50 | Compare |
|
AZN
AstraZeneca PLC
|
$188.41
|
$261.56B | 30.8 | 64 | Compare |
|
NVS
Novartis AG
|
$151.04
|
$254.99B | 20.4 | 67 | Compare |
|
ABT
Abbott Laboratories
|
$109.41
|
$232.30B | 28.5 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$113.37
|
$225.13B | 14.3 | 60 | Compare |
|
PFE
Pfizer Inc.
|
$26.66
|
$154.70B | 15.2 | 69 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$47.27
|
$121.27B | 19.4 | 57 | Compare |
More BLRX Analysis
Data updated: Feb 02, 2026 | Industry: Pharmaceutical Preparations (SIC 2834)
553 stocks in this industry